Clinical Trial Update: Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) [Phase 1]

View source ↗

Summary

KRYSTAL 14 is a Phase 1 trial evaluating adagrasib in combination with BI-1701963 in patients with advanced or metastatic cancer; the trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Colon Cancer
• Lung Cancer

Drugs mentioned

• Adagrasib (adagrasib)
• BI-1701963 (BI-1701963)

Snippet

Sponsor: Mirati Therapeutics Inc. | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: TERMINATED